Literature DB >> 32449264

A war of attrition against antibiotic resistance: Current strategies try to keep antibiotic resistance at bay and further encourage research to produce genuinely novel antibacterials.

Philip Hunter1.   

Abstract

To fight antibiotic resistance, novel drugs are urgently needed. Regulatory agencies are addressing the economic problems and offer new incentives for developing new antibiotics.
© 2020 The Author.

Mesh：

Substances：

Year:  2020        PMID： 32449264      PMCID： PMC7271335          DOI： 10.15252/embr.202050807

Source DB:  PubMed          Journal:  EMBO Rep        ISSN： 1469-221X            Impact factor:   8.807


  9 in total

Review 1.  Potential of old-generation antibiotics to address current need for new antibiotics.

Authors:  Matthew E Falagas; Alexandros P Grammatikos; Argyris Michalopoulos
Journal:  Expert Rev Anti Infect Ther       Date:  2008-10       Impact factor: 5.091

Review 2.  Eravacycline, a newly approved fluorocycline.

Authors:  Young Ran Lee; Caitlin Elizabeth Burton
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-06-07       Impact factor: 3.267

Review 3.  The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria.

Authors:  Xian-Zhi Li; Patrick Plésiat; Hiroshi Nikaido
Journal:  Clin Microbiol Rev       Date:  2015-04       Impact factor: 26.132

Review 4.  Non-traditional Antibacterial Therapeutic Options and Challenges.

Authors:  Ursula Theuretzbacher; Laura J V Piddock
Journal:  Cell Host Microbe       Date:  2019-07-10       Impact factor: 21.023

Review 5.  Bacteriocins - a viable alternative to antibiotics?

Authors:  Paul D Cotter; R Paul Ross; Colin Hill
Journal:  Nat Rev Microbiol       Date:  2012-12-24       Impact factor: 60.633

6.  Application of Antimicrobial Peptides of the Innate Immune System in Combination With Conventional Antibiotics-A Novel Way to Combat Antibiotic Resistance?

Authors:  Maria S Zharkova; Dmitriy S Orlov; Olga Yu Golubeva; Oleg B Chakchir; Igor E Eliseev; Tatyana M Grinchuk; Olga V Shamova
Journal:  Front Cell Infect Microbiol       Date:  2019-04-30       Impact factor: 5.293

Review 7.  The Science of Antibiotic Discovery.

Authors:  Kim Lewis
Journal:  Cell       Date:  2020-03-19       Impact factor: 41.582

Review 8.  The Super-Donor Phenomenon in Fecal Microbiota Transplantation.

Authors:  Brooke C Wilson; Tommi Vatanen; Wayne S Cutfield; Justin M O'Sullivan
Journal:  Front Cell Infect Microbiol       Date:  2019-01-21       Impact factor: 5.293

9.  Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.

Authors:  Fei Zhou; Ting Yu; Ronghui Du; Guohui Fan; Ying Liu; Zhibo Liu; Jie Xiang; Yeming Wang; Bin Song; Xiaoying Gu; Lulu Guan; Yuan Wei; Hui Li; Xudong Wu; Jiuyang Xu; Shengjin Tu; Yi Zhang; Hua Chen; Bin Cao
Journal:  Lancet       Date:  2020-03-11       Impact factor: 79.321
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.